Recalls & Warnings May 01, 2023 TruVision Recalls Products Due to Presence of Potentially Dangerous Ingredients On April 27, 2023, TruVision Health issued a recall of various dietary supplement products because they contain hordenine and/or octodrine/DMHA, compounds that the FDA considers to be possibly unsafe and which are not permitted to be sold as dietary supplements
Generic Drugs Market The U.S
Transitioning to Maintenance Therapy Once the deficiency is managed, patients move to maintenance therapy
Carroll stresses that while these complications are rare, theyre the reason GLP-1 medications require clinician oversight rather than self-administration
That does not mean tirzepatide is automatically the best choice for every patient, but it does suggest it may produce stronger average results for weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] He M, Hou J, Wang L, Zheng M, Fang T, Wang X, Xia J, 2017